NCT02548325

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,001 (actual)
• Sponsor: Corporacion Parc Tauli · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the prevalence of hepatitis B in Vallés Occidental. Also, describe the stage of the disease, and whether if they are under medical treatment or not.

Detailed description

The hepatitis B virus ( HBV ) is a global health problem . It is estimated that in the world there are about 350-400 million carriers of HBV surface antigen ( HBsAg ) 1 . The prevalence in Spain is estimated at a 2-7 % and is considered a second intermediate prevalence. For over 20 years, has carried out a program of primary prevention through universal vaccination against hepatitis B including it in the childhood vaccination schedule and has already been observed that in some estudi3 the prevalence has declined . For this reason , we want to evaluate what is the currently prevalence in our area of influence. There aren't recent studies to assess what is the current status of these patients ( how many , what risk factors which needs of treatment and with answer ...)

Conditions

• Hepatitis B

Interventions

Type	Name	Description
OTHER	Not apply	None. Just registration epidemiology dates

Timeline

• Start date: 2014-06-01
• Primary completion: 2015-05-31
• Completion: 2017-07-01
• First posted: 2015-09-14
• Last updated: 2019-02-01

Locations

1 site across 1 country: Spain